Access cutting-edge chlamydia infection treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access chlamydia infection specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chlamydia infection treatment provided free
This is a Phase 4 blinded, randomized, active-controlled, non-inferiority trial. Final evaluable population will include a minimum 596 individuals: 298 women with confirmed urogenital chlamydia (CT) and 298 men with confirmed rectal chlamydia (CT). Approximately 664 participants will be enrolled to achieve a minimum 596 participants who contribute primary outcome data. Randomization will be stratified by study site and sex: 332 women and 332 men. Participants will be randomized 1:1 to a 3-day re
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Check if you qualify for this chlamydia infection clinical trial in Atlanta, GA
If you're searching for chlamydia infection treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chlamydia infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.